Join
Live feed
·
INSIDERFilingvia Quantisnow
POINT Biopharma Global Inc. logo

SEC Form 4: Mccann Joe A. bought $14,342 worth of shares (2,160 units at $6.64), increasing direct ownership by 0.06% to 3,616,313 units

ByQuantisnow·Wall Street's wire, on your screen.
PNT· POINT Biopharma Global Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PNT (POINT Biopharma Global Inc.) and more on Quantisnow.